Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ragini Kudchadkar

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Ochsner Journal|May 24, 2011
Novel targeted therapies for the treatment of metastatic melanomaRagini Kudchadkar
Current Problems in Cancer|April 8, 2010
Systemic treatments for merkel cell carcinomaRagini Kudchadkar, Ronald Deconti
The Lancet. Oncology|January 25, 2011
Adjuvant interferon: recommit or move on?Ragini Kudchadkar, Vernon Sondak
The Oncologist|September 25, 2012
Pegylated interferon for the adjuvant treatment of melanoma: FDA approved, but what is its role?Vernon K Sondak, Ragini Kudchadkar
Seminars in Oncology|April 10, 2012
Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitorsRagini Kudchadkar, Karl Lewis, Rene Gonzalez
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2018
Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapyTyler Beardslee, Amber Draper, Ragini Kudchadkar
Expert Opinion on Investigational Drugs|October 17, 2008
PI-88: a novel inhibitor of angiogenesisRagini Kudchadkar, Rene Gonzalez, Karl D Lewis
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Integrating molecular biomarkers into current clinical management in melanomaRagini Kudchadkar, Geoffrey Gibney, Vernon K Sondak
Surgical Oncology Clinics of North America|November 30, 2010
Adjuvant therapy for melanoma: a surgical perspectiveVernon K Sondak, Ricardo J Gonzalez, Ragini Kudchadkar
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Systemic Therapy Options for Patients With Unresectable MelanomaMelinda Yushak, Paul Chapman, Caroline Robert, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Ochsner Journal|May 24, 2011
Novel targeted therapies for the treatment of metastatic melanomaRagini Kudchadkar
Current Problems in Cancer|April 8, 2010
Systemic treatments for merkel cell carcinomaRagini Kudchadkar, Ronald Deconti
The Lancet. Oncology|January 25, 2011
Adjuvant interferon: recommit or move on?Ragini Kudchadkar, Vernon Sondak
The Oncologist|September 25, 2012
Pegylated interferon for the adjuvant treatment of melanoma: FDA approved, but what is its role?Vernon K Sondak, Ragini Kudchadkar
Seminars in Oncology|April 10, 2012
Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitorsRagini Kudchadkar, Karl Lewis, Rene Gonzalez
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2018
Tacrolimus for the treatment of immune-related adverse effects refractory to systemic steroids and anti-tumor necrosis factor α therapyTyler Beardslee, Amber Draper, Ragini Kudchadkar
Expert Opinion on Investigational Drugs|October 17, 2008
PI-88: a novel inhibitor of angiogenesisRagini Kudchadkar, Rene Gonzalez, Karl D Lewis
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Integrating molecular biomarkers into current clinical management in melanomaRagini Kudchadkar, Geoffrey Gibney, Vernon K Sondak
Surgical Oncology Clinics of North America|November 30, 2010
Adjuvant therapy for melanoma: a surgical perspectiveVernon K Sondak, Ricardo J Gonzalez, Ragini Kudchadkar
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Systemic Therapy Options for Patients With Unresectable MelanomaMelinda Yushak, Paul Chapman, Caroline Robert, et al.
Pageof 5